Cargando…

The p53 tumor suppressor protein protects against chemotherapeutic stress and apoptosis in human medulloblastoma cells

Medulloblastoma (MB), a primitive neuroectodermal tumor, is the most common malignant childhood brain tumor and remains incurable in about a third of patients. Currently, survivors carry a significant burden of late treatment effects. The p53 tumor suppressor protein plays a crucial role in influenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waye, Sarah, Naeem, Aisha, Choudhry, Muhammad Umer, Parasido, Erika, Tricoli, Lucas, Sivakumar, Angiela, Mikhaiel, John P., Yenugonda, Venkata, Rodriguez, Olga C., Karam, Sana D., Rood, Brian R., Avantaggiati, Maria Laura, Albanese, Chris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637210/ https://www.ncbi.nlm.nih.gov/pubmed/26540407

Ejemplares similares

The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells
por: Ringer, Lymor, et al.
Publicado: (2014)

Regulation of Chemosensitivity in Human Medulloblastoma Cells by p53 and the PI3 Kinase Signaling Pathway
por: Naeem, Aisha, et al.
Publicado: (2022)

Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cells
por: Tricoli, Lucas, et al.
Publicado: (2017)

Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient‐derived primary prostate cells
por: Naeem, Aisha, et al.
Publicado: (2020)

Quantifying the CDK inhibitor VMY-1-103’s activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI
por: Sirajuddin, Paul, et al.
Publicado: (2012)

The SLC25A1-p53 mutant crosstalk
por: Albanese, Chris, et al.
Publicado: (2015)

Expansion of human amniotic epithelial cells using condition cell reprogramming technology
por: Naeem, Aisha, et al.
Publicado: (2022)

Clinicopathologic and prognostic significance of LGR5, a cancer stem cell marker in patients with colorectal cancer
por: Ihemelandu, Chukwuemeka, et al.
Publicado: (2019)

MBRS-18. TUMOR SUPPRESSOR p53 DEFINES THE THERAPEUTIC RESPONSES IN TREATMENT OF MEDULLOBLASTOMA
por: Mohan, Avinash L, et al.
Publicado: (2020)

Comparison of in vitro activity of epipodophyllotoxins with other chemotherapeutic agents in human medulloblastomas.
por: Tomlinson, F. H., et al.
Publicado: (1991)

Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization
por: Bhatia, Shilpa, et al.
Publicado: (2015)

Tumour suppressor genes in chemotherapeutic drug response
por: Lai, Dulcie, et al.
Publicado: (2012)

Chemotherapeutic targeting of myeloid-derived suppressor cells
por: Alizadeh, Darya, et al.
Publicado: (2014)

Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma
por: Bhatia, Shilpa, et al.
Publicado: (2017)

Germline microsatellite genotypes differentiate children with medulloblastoma
por: Rivero-Hinojosa, Samuel, et al.
Publicado: (2020)

EZH2 targeting in medulloblastoma reduces tumor growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway
por: Zhang, Hanwen, et al.
Publicado: (2019)

Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model
por: Bhatia, Shilpa, et al.
Publicado: (2015)

Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH
por: Tan, Mingjun, et al.
Publicado: (2020)

A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma Tumors
por: Staal, Jerome A., et al.
Publicado: (2016)

MBRS-53. CONTROL OF MEDULLOBLASTOMA VASCULATURE BY A REGULATOR OF NEUROGENESIS
por: Shaik, Shavali, et al.
Publicado: (2020)

Recent advances in SHH medulloblastoma progression: tumor suppressor mechanisms and the tumor microenvironment
por: Tamayo-Orrego, Lukas, et al.
Publicado: (2019)

TMOD-06. LOSS OF DICER COOPERATES WITH TUMOR SUPPRESSORS TO INITIATE METASTATIC MEDULLOBLASTOMA
por: Alcantara Llaguno, Sheila, et al.
Publicado: (2021)

Activation of p53 by Chemotherapeutic Agents Enhances Reovirus Oncolysis
por: Pan, Da, et al.
Publicado: (2013)

Estrogen and soy isoflavonoids decrease sensitivity of medulloblastoma and central nervous system primitive neuroectodermal tumor cells to chemotherapeutic cytotoxicity
por: Belcher, Scott M., et al.
Publicado: (2017)

Medulloblastoma: From TP53 Mutations to Molecular Classification and Liquid Biopsy
por: Eibl, Robert H., et al.
Publicado: (2023)

SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker
por: Kolukula, Vamsi K., et al.
Publicado: (2014)

An expanded role for Caveolin-1 in brain tumors
por: Tanowitz, Herbert B., et al.
Publicado: (2013)

Tumor suppressor p53 and metabolism
por: Liu, Juan, et al.
Publicado: (2018)

BIOL-07. MIR-212 FUNCTIONS AS A TUMOR SUPPRESSOR GENE IN GROUP 3 MEDULLOBLASTOMA VIA TARGETING NUCLEAR FACTOR I/B (NFIB)
por: Perumal, Naveenkumar, et al.
Publicado: (2021)

MBRS-72. MiR-212 FUNCTIONS AS A TUMOR SUPPRESSOR GENE IN GROUP 3 MEDULLOBLASTOMA VIA TARGETING NUCLEAR FACTOR I/B (NFIB)
por: Perumal, Naveenkumar, et al.
Publicado: (2020)

The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma.
por: Cowan, R., et al.
Publicado: (1997)

BIOL-23. LOSS OF MICRORNAS COOPERATES WITH TUMOR SUPPRESSORS TO INITIATE MYC-DEPENDENT METASTATIC MEDULLOBLASTOMA
por: Llaguno, Sheila Alcantara, et al.
Publicado: (2023)

RITA displays anti-tumor activity in medulloblastomas independent of TP53 status
por: Gottlieb, Aline, et al.
Publicado: (2017)

Pre- and Post-Zygotic TP53 De Novo Mutations in SHH-Medulloblastoma
por: Azzollini, Jacopo, et al.
Publicado: (2020)

EMBR-23. KIF11 DEPENDENCY ON P53 MUTATIONAL STATUS IN MEDULLOBLASTOMA
por: Huang, Shiying, et al.
Publicado: (2021)

p53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs.
por: Malcomson, R. D., et al.
Publicado: (1995)

A novel role of HLA class I in the pathology of medulloblastoma
por: Smith, Courtney, et al.
Publicado: (2009)

Microbial Regulation of p53 Tumor Suppressor
por: Zaika, Alexander I., et al.
Publicado: (2015)

p53: not just a tumor suppressor
por: Oren, Moshe
Publicado: (2019)

Understanding p53 tumour suppressor network
por: Panatta, Emanuele, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bh5ulttto4snhjevisc9n2c4ca